Dashboard
Regeneron Pharmaceuticals, Inc.
REGNNASDAQFor informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.
Universal block
Live market data + trailing fundamentals.
Recent events
Material filings, federal awards, and regulatory activity. Impact is scored against market cap.
- Nov 18Ownership changeSEC
SEC Form 4 insider transaction filing.
- Nov 18Ownership changeSEC
SEC Form 4 filing reporting change in beneficial ownership by insider at Regeneron Pharmaceuticals.
- Nov 18Ownership changeSEC
SEC Form 4 filed reporting change in beneficial ownership.
- Nov 6Ownership changeSEC
SEC Form 4 filed reporting change in insider beneficial ownership.
- Nov 5Ownership changeSEC
SEC Form 4 insider transaction filing.
- Nov 5Ownership changeSEC
SEC Form 4 insider transaction filing.
- Nov 4Ownership changeSEC
SEC Form 4 insider transaction filing.
- Nov 4Ownership changeSEC
SEC Form 4 insider transaction filing.
- Nov 4Ownership changeSEC
Form 4 filing reporting change in beneficial ownership by insider.
- Nov 4Ownership changeSEC
SEC Form 4 filing for change in beneficial ownership by insider at REGN.
- Nov 3Ownership changeSEC
SEC Form 4 insider transaction filing.
- Nov 3Ownership changeSEC
Form 4 filing reporting change in beneficial ownership by insider.
- Nov 3Ownership changeSEC
Form 4 filing reporting change in beneficial ownership.
- Oct 30Financial resultsSEC
8-K filing (items 2.02, 9.01) disclosing financial results and exhibits.
- Oct 15Ownership changeSEC
Form 4 insider transaction filing.
- Oct 6OtherSEC
8-K filing with items 1.01 (material agreement), 2.02 (financial condition), and 8.01 (other events).
- Sep 30LeadershipSEC
8-K filing with items 5.02 and 9.01 disclosing officer departure or appointment.
- Sep 3Ownership changeSEC
Form 4 filing reporting change in beneficial ownership.
- Sep 3Ownership changeSEC
SEC Form 4 insider transaction report filed.
- Aug 21Ownership changeSEC
SEC Form 4 filing for change in beneficial ownership at Regeneron Pharmaceuticals.
Not financial advice — research and opinion only. Disclosures